Re: Adjuvant Treatment of High-Risk, Radically Resected Gastric Cancer Patients with 5-Fluorouracil, Leucovorin, Cisplatin, and Epidoxorubicin in a Randomized Controlled Trial

20074 citationsletterbronze Open Access

Authors

Good health and well-being

Published in: JNCI Journal of the National Cancer Institute

Volume 99, Issue 17, pp. 1345-1346

Field-Weighted Citation Impact: 0.27